45. Edger,P.P. and Pires,J.C. (2009) Gene and genome duplications: the impact of dosage-sensitivity on the fate of nuclear genes. Chromosome Res., 17, 699–717. 46. Kennison,J.A. and Russell,M.A. (1987) Dosage-dependent modiﬁers of homoeotic mutations in Drosophila melanogaster. Genetics, 116, 75–86. 47. Campbell,R.B., Sinclair,D.A., Couling,M. and Brock,H.W. (1995) Genetic interactions and dosage effects of Polycomb group genes of Drosophila. Mol. Gen. Genet., 246, 291–300. 48. Henikoff,S. (1996) Dosage-dependent modiﬁcation of position-effect variegation in Drosophila. BioEssays, 18, 401–409. 49. Tartof,K.D., Bishop,C., Jones,M., Hobbs,C.A. and Locke,J. (1989) Towards an understanding of position effect variegation. Dev. Genet., 10, 162–176. 50. Locke,J., Kotarski,M.A. and Tartof,K.D. (1988) Dosage-dependent modiﬁers of position effect variegation in Nucleic Acids Research, 2011, Vol. 39, No. 15 6439 Drosophila and a mass action model that explains their effect. Genetics, 120, 181–198. 51. Kageyama,Y., Mengus,G., Gilﬁllan,G., Kennedy,H.G., Stuckenholz,C., Kelley,R.L., Becker,P.B. and Kuroda,M.I. (2001) Association and spreading of the Drosophila dosage compensation complex from a discrete roX1 chromatin entry site. EMBO J., 20, 2236–2245. 52. Park,Y., Mengus,G., Bai,X., Kageyama,Y., Meller,V.H., Becker,P.B. and Kuroda,M.I. (2003) Sequence-speciﬁc targeting of Drosophila roX genes by the MSL dosage compensation complex. Mol. Cell, 11, 977–986. 53. Park,S.W., Kuroda,M.I. and Park,Y. (2008) Regulation of histone H4 Lys16 acetylation by predicted alternative secondary structures in roX noncoding RNAs. Mol. Cell. Biol., 28, 4952–4962.